![Kelly Gold](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 297 980 $ in data 31/05/2026
Kelly Gold is currently Director & Director-Individual Fundraising at Education First, Independent Director at X4 Pharmaceuticals, Inc. starting in 2026, and Chief Financial Officer at CAMP4 Therapeutics Corp.
since 2022.
Former roles include Associate Director-Strategic Corporate Finance at Biogen, Inc. from 2014 to 2017 and Partner at Deutsche Bank AG (New York Branch) from 2009 to 2013.
Education includes an undergraduate degree from Queen's University and an MBA from MIT Sloan School of Management.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 01/04/2026 | 67.877 ( 0,14% ) | 297 980 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| CAMP4 THERAPEUTICS CORPORATION | Direttore Finanziario/CFO | 01/04/2022 |
| X4 PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 01/06/2026 |
Education First
 Education First Investment Trusts/Mutual FundsMiscellaneous Offers scholarship programs | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01/01/2017 |
Deutsche Bank AG (New York Branch)
 Deutsche Bank AG (New York Branch) Regional BanksFinance Provides financial and investment banking services | Corporate Officer/Principal | 01/01/2013 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 7 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Deutsche Bank AG (New York Branch)
Deutsche Bank AG (New York Branch) Regional BanksFinance Provides financial and investment banking services | Finance |
Queen's University
 Queen's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Education First
Education First Investment Trusts/Mutual FundsMiscellaneous Offers scholarship programs | Miscellaneous |
MIT Sloan School of Management
 MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Camp4 Therapeutics Corp.
 Camp4 Therapeutics Corp. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in the development of regulatory RNA-based therapeutics | Health Technology |
X4 Pharmaceuticals, Inc.
 X4 Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
